Nextleaf Solutions (OILS) AI Stock Analysis

19 Followers

Nextleaf Solutions

(CNQX:OILS)

Select Model

Rating:41Neutral

Price Target:CAD 0.01▼(-44.00% Downside)

Action:reiterated

Date:11/03/26

The score is primarily constrained by deteriorating profitability and revenue momentum, with additional pressure from strongly bearish technical indicators and a negative P/E ratio. Improved leverage and positive recent cash flow provide limited support but do not offset the broader risks.

Positive Factors

Low leverageManageable leverage and positive equity provide financial flexibility while reducing balance-sheet pressure. Lower debt can preserve capacity to fund processing capabilities, commercial opportunities, or working capital without creating the interest burden associated with heavier borrowing.

Negative Factors

Revenue contractionDeclining revenue indicates that current demand, customer activity, or realized business volume is not yet expanding consistently. Continued contraction would limit operating leverage, weaken the company’s ability to absorb fixed costs, and make it harder to convert its processing platform into durable growth.

Nextleaf Solutions (OILS) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 3.40M
Dividend Yield: ―
Average Volume (3M): 106.56K
Price to Earnings (P/E): -2.2
Beta (1Y): 1.63
Revenue Growth: -18.30%
EPS Growth: -397.37%
Country: Canada
Employees: 26
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Nextleaf Solutions Business Overview & Revenue Model

Company Description

Nextleaf Solutions Ltd. operates as a cannabis extraction technology enterprise, pioneering and licensing advanced methods for the processing, refinement, and development of cannabinoid formulations throughout Canada. The company is actively involved...

How the Company Makes Money

Nextleaf Solutions makes money primarily through B2B cannabis processing and ingredient sales within regulated markets. Key revenue streams include: (1) selling bulk cannabinoid ingredients (e.g., refined cannabis oils/distillates) to licensed cannab...

Nextleaf Solutions Financial Statement Overview

Summary

Improving cash flow and materially lower leverage are positives, but declining revenue, recurring losses, negative gross margin in the 2026 TTM, and deeply negative returns on equity indicate substantial financial weakness.

Income Statement

38Negative

Balance Sheet

55Neutral

Cash Flow

62Positive

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	9.90M	11.26M	12.48M	8.18M	4.41M	3.38M
Gross Profit	-400.34K	1.94M	3.74M	2.31M	661.24K	-855.03K
EBITDA	-1.42M	611.70K	-749.47K	1.11M	-1.94M	-3.79M
Net Income	-1.92M	-162.94K	-1.44M	223.33K	-3.49M	-5.39M
Balance Sheet
Total Assets	7.74M	7.82M	8.57M	8.54M	7.15M	9.19M
Cash, Cash Equivalents and Short-Term Investments	92.08K	446.56K	438.54K	898.90K	377.72K	915.38K
Total Debt	394.74K	793.82K	384.69K	489.75K	1.36M	3.25M
Total Liabilities	3.95M	3.25M	4.06M	4.40M	4.14M	5.77M
Stockholders Equity	3.78M	4.57M	4.50M	4.13M	3.02M	3.43M
Cash Flow
Free Cash Flow	246.84K	353.16K	-682.48K	851.89K	-911.02K	-2.94M
Operating Cash Flow	327.56K	414.88K	-614.09K	875.46K	-802.19K	-2.87M
Investing Cash Flow	-303.69K	-267.79K	-68.39K	-23.56K	-108.83K	-21.48K
Financing Cash Flow	-175.00K	-139.06K	222.12K	-330.71K	373.35K	2.82M

Nextleaf Solutions Technical Analysis

Technical Analysis SentimentNeutral

Last Price0.03

Price Trends

50DMA0.03Negative

100DMA0.04Negative

200DMA0.04Negative

Market Momentum

MACD-0.00Negative

RSI56.24Neutral

STOCH66.67Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:OILS, the sentiment is Neutral. The current price of 0.03 is above the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.03, and below the 200-day MA of 0.04, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 56.24 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:OILS.

Nextleaf Solutions Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

TSE:OILS against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:LOVE	77Outperform	CAD 200.53M	17.87	9.45%	―	14.66%	-33.72%
TSE:OGI	59Neutral	CAD 166.39M	1.83	21.99%	―	38.14%	2030.00%
TSE:LABS	57Neutral	CAD 27.77M	-10.00	-7.66%	―	-9.31%	66.84%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:ATLE	42Neutral	CAD 44.29M	-0.76	-2099.75%	―	-96.13%	88.13%
TSE:OILS	41Neutral	CAD 4.26M	-2.19	-43.92%	―	-18.30%	-397.37%

* Healthcare Sector Average

Performance Comparison

TSE:OILS and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:OILS	Nextleaf Solutions	0.03	-0.03	-54.55%
TSE:ATLE	Willow Biosciences	0.10	-0.08	-44.12%
TSE:OGI	Organigram Global Inc.	1.18	-0.94	-44.34%
TSE:LABS	Medipharm Labs (Otc)	0.07	-0.01	-7.14%
TSE:LOVE	Cannara Biotech, Inc.	2.03	0.42	26.09%
TSE:HASH	Simply Solventless Concentrates Ltd	0.04	-0.19	-82.61%

Nextleaf Solutions Corporate Events

Business Operations and StrategyExecutive/Board Changes

Nextleaf Solutions Launches Strategic Review as CFO Sam Kassem Steps In as Interim CEO

Neutral

Sep 16, 2026

Innovation-driven cannabis processor Nextleaf Solutions has announced a leadership change as Chief Executive Officer, President and director Emma Andrews steps down after eight years with the company. Andrews, who helped transform Nextleaf into a con...

Business Operations and StrategyFinancial Disclosures

Nextleaf Narrows Loss as Glacial Gold Strengthens Market Position

Positive

Sep 3, 2026

Nextleaf Solutions reported fiscal third-quarter 2026 results showing modest sequential revenue growth and a sharply reduced net loss, aided by a product mix shift that cut excise taxes by nearly a third. Net revenue rose 5% to about $2.53 million, g...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 03, 2026

Nextleaf Solutions AI Stock Analysis